Navigation Links
CardioWise™ Completes Small Business Innovation and Research Grant from the National Science Foundation

Fayetteville, AK (PRWEB) January 10, 2014

CardioWise, Inc. has completed National Science Foundation (NSF) Phase I and IB Small Business Innovation and Research (SBIR) grants that continued the development and commercialization of a non-invasive analysis method for detection of heart disease. The final report submitted to the NSF in December detailed the research and development milestones that were achieved during the 2013 award period including:

  •     Development and testing of cloud-based software as a service (SaaS) solution that supports upload of magnetic resonance images (MRI) to CardioWise for analysis, and download of CardioWise analysis to any browser-based device in compliance with the Health Insurance Portability and Accountability Act (HIPAA) and Certified Electronic Health Record Technology (CEHRT). This allows the analysis to be sent to any mobile device so that providers, doctors and patients can see and understand the diagnosis and actively participate in decisions about treatment.
  •     Automation and testing of software components of the MRI analysis currently being done by hand reducing total analysis time from 6 hours to less than 30 minutes, allowing the entire image acquisition and analysis to be completed in a single office visit.
  •     Clinical validation testing of the CardioWise analysis software on separate MRI scans acquired on the same patient on the same MRI, as well as scans acquired on the same patient but on different MRI systems. This validation is important for regulatory submission and clearance and also to insure patient safety.

The CardioWise analysis software is uniquely capable of analyzing the three-dimensional motion of the heart that is acquired from cardiac MRI images and then comparing the analysis at 15,300 points to the motion of a normal heart model. The analysis detects portions of the heart that are moving abnormally and demonstrates to what degree the heart muscle has been affected. Since MRI uses no ionizing radiation or contrast, it is completely non-invasive and poses no risk to the patient. This diagnostic analysis method may aid doctors to determine what intervention, such as surgery, stent insertion, or drug is most appropriate for the patient who presents with cardiovascular disease symptoms.

CardioWise analysis software is a platform technology that can analyze heart contractile motion from other imaging modalities just as well as images acquired from MRI systems. In cardiac ultrasound (echocardiogram) and computerized tomographic (CT) images wall motion, recognizable patterns and easily identifiable cardiac anatomy may be tracked to produce input to CardioWise for analysis. The company’s long-term strategy is to address all of these available markets with its platform analysis product.

The NSF Phase I and IB SBIR awards are intended to incentivize and support small and early stage businesses to undertake research and development with high technical risk and high commercial reward. To qualify for the award, there must be significant societal impact and significant market opportunity from the technology developed.

CardioWise™ is commercializing patent-pending, non-invasive Cardiac Magnetic Resonance Imaging (cMRI) analysis software that produces a quantified 4D image model of the human heart, called Multiparametric Strain (MPS™) heart analysis. CardioWise heart analysis software combined with cardiac MRI is a single diagnostic test that is able to provide quantitative analysis of the myocardium, arteries and valves with an unprecedented level of detail. It has the opportunity to become the new gold standard of care for heart health analysis. CardioWise™ is a VIC Technology Venture Development™ portfolio company.

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. EliNext Completes Development of a Series of Virtual Reality Interactive 5D Simulation Games on Unity 3D
2. Mayo Clinic completes first genome-wide analysis of peripheral T-cell lymphomas
3. IRSC Student Completes 75-Hours of Work for Degree at Martin County PPEC
4. Halcyon Completes First Acquisition in South Georgia
5. Dr. Silberg Completes LANAP Laser Evolution 5 Training
6. University of Maine Football Completes Ground-Breaking Team Leadership and Emotional Intelligence Training Program
7. HealthSmart Completes Acquisition of Wells Fargo Disability Management Unit
8. HealthSmart Completes Acquisition of Klais & Company, Inc.
9. HeartStitch Medical Successfully Completes Transapical Access and Closure
10. AMG Completes Compliance Procedures to Make Live Venues More Accessible
11. Dr. David Perna of Back and Body Medical in Midtown Manhattan Completes Ironman 70.3 Syracuse, Gains New Perspective on Patients’ Fitness Goals and Training Requirements
Post Your Comments:
(Date:6/26/2016)... Carolina (PRWEB) , ... June 26, 2016 , ... ... of a new product that was developed to enhance the health of felines. The ... centuries. , The two main herbs in the PawPaws Cat Kidney Support ...
(Date:6/25/2016)... ... June 25, 2016 , ... Austin residents seeking Mohs surgery services, can ... Surgery and to Dr. Russell Peckham for medical and surgical dermatology. , Dr. Dorsey ... cancer. The selective fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey was under ...
(Date:6/25/2016)... , ... June 25, 2016 , ... As a lifelong ... Cum Laude and his M.D from the David Geffen School of Medicine at UCLA. ... to Los Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai ...
(Date:6/24/2016)... ... 24, 2016 , ... A recent article published June 14 on ... article goes on to state that individuals are now more comfortable seeking to undergo ... such as calf and cheek reduction. The Los Angeles area medical group, Beverly Hills ...
(Date:6/24/2016)... , ... June 24, 2016 , ... ... and Scientific Sessions in Dallas that it will receive two significant new grants ... grants came as PHA marked its 25th anniversary by recognizing patients, medical professionals ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... 2016 Capricor Therapeutics, Inc. ... biotechnology company focused on the discovery, development and ... enrollment in its ongoing randomized HOPE-Duchenne clinical trial ... of its 24-patient target. Capricor expects the trial ... of 2016, and to report top line data ...
(Date:6/23/2016)... BOGOTA, Colombia , June 23, 2016  Astellas today announced the establishment of Astellas Farma Colombia (AFC), a ... second affiliate in Latin America . ... ... ... ...
(Date:6/23/2016)... 23, 2016  Experian Health, the healthcare ... the patient payment and care experience, today ... products and services that will enhance the ... offerings. These award-winning solutions will enable healthcare ... compliant in an ever-changing environment and redefine ...
Breaking Medicine Technology: